Evidence map›Paper›PMID 29610294›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Learned immunosuppressive placebo responses in renal transplant patients.

Julia Kirchhof, Liubov Petrakova, Alexandra Brinkhoff, Sven Benson, Justine Schmidt, Maike Unteroberdörster, Benjamin Wilde, Ted J Kaptchuk, Oliver Witzke, Manfred Schedlowski

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 42 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06365892 narecruitingnot on this mapstarted 2024, after this paper: background citation

Effectiveness of Conditioning + Open-label Placebo for the Management of Pain in Children Who Undergo Surgical Treatment of Idiopathic Scoliosis

TypeinterventionalSponsorUniversity of California, San FranciscoRan2024 to 2026Enrolled64ConditionsAdolescent Idiopathic Scoliosis (AIS)Armsopen-label placebo, Treatment as usual
NCT07373210 narecruitingnot on this mapstarted 2026, after this paper: background citation

Conditioning, Open-label Placebo for Pain Management in Adolescents and Young Adults Undergoing Bernese Periacetabular Osteotomy (PAO)

TypeinterventionalSponsorUniversity of California, San FranciscoRan2026 to 2028Enrolled64ConditionsPeriacetabular Osteotomy, OpiatesArmsOpen-Label Placebo, Treatment as usual
3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 2 syntheses or guidelines pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Review
  14. Article
  15. The Effects of Fingolimod (FTY720) on Leukocyte Subset Circulation cannot be Behaviourally Conditioned in Rats.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2024
    Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 3 countries.

Julia KirchhofInstitute of Medical Psychology and Behavioral Immunobiology, University Hospital Essen, University of Duisburg-Essen, 45122 Essen, Germany.
Liubov PetrakovaInstitute of Medical Psychology and Behavioral Immunobiology, University Hospital Essen, University of Duisburg-Essen, 45122 Essen, Germany.
Alexandra BrinkhoffDepartment of Nephrology, University Hospital Essen, University of Duisburg-Essen, 45122 Essen, Germany.
Sven BensonInstitute of Medical Psychology and Behavioral Immunobiology, University Hospital Essen, University of Duisburg-Essen, 45122 Essen, Germany.
Justine SchmidtInstitute of Medical Psychology and Behavioral Immunobiology, University Hospital Essen, University of Duisburg-Essen, 45122 Essen, Germany.
Maike UnteroberdörsterClinic of Neurosurgery, University Hospital Essen, University of Duisburg-Essen, 45122 Essen, Germany.
Benjamin WildeDepartment of Nephrology, University Hospital Essen, University of Duisburg-Essen, 45122 Essen, Germany.
Ted J KaptchukProgram in Placebo Studies, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA 02215.
Oliver WitzkeDepartment of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, 45122 Essen, Germany.
Manfred SchedlowskiInstitute of Medical Psychology and Behavioral Immunobiology, University Hospital Essen, University of Duisburg-Essen, 45122 Essen, Germany; manfred.schedlowski@uk-essen.de.
University of Duisburg-Essen · DEHarvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients after organ transplantation or with chronic, inflammatory autoimmune diseases require lifelong treatment with immunosuppressive drugs, which have toxic adverse effects. Recent insight into the neurobiology of placebo responses shows that associative conditioning procedures can be employed as placebo-induced dose reduction strategies in an immunopharmacological regimen. However, it is unclear whether learned immune responses can be produced in patient populations already receiving an immunosuppressive regimen. Thus, 30 renal transplant patients underwent a taste-immune conditioning paradigm, in which immunosuppressive drugs (unconditioned stimulus) were paired with a gustatory stimulus [conditioned stimulus (CS)] during the learning phase. During evocation phase, after patients were reexposed to the CS, T cell proliferative capacity was significantly reduced in comparison with the baseline kinetics of T cell functions under routine drug intake (ƞ

Indexed as

Conditioning, ClassicalKidney TransplantationLymphocyte ActivationPlacebo EffectAdministration, OralAdultAffectAssociationCatecholaminesCyclosporineDose-Response Relationship, DrugDose-Response Relationship, ImmunologicFemaleHemodynamicsHumansHydrocortisoneCatecholaminesCyclosporineHydrocortisoneImmunosuppressive AgentsPlacebosTacrolimusconditioningimmunosuppressionplaceboT cellstransplantation

Identifiers

PMID29610294
PMCPMC5910853
OpenAlexW2796377860

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.